Together, these data clearly support our results in 3xTg-AD mice, suggesting that CD103–CD8+ T cells play a negative role in AD and that blocking GrK activity and its interaction with PAR-1 may have therapeutic value to reduce neuronal dysfunction and cognitive decline in AD. Here, CD8A is linked to Alzheimer disease.